← NDC auxiliary source history
FDA Establishment Identifier 118984002
Every current compounder row and every parsed outsourcing-response revision row carrying this exact FEI. Repeated physical rows and parser-specific revisions remain visible.
Establishment names in FDA source rows#
| Exact source name |
|---|
| Turbare Manufacturing |
Current compounder rows#
| Current source record | Source row | Product NDC | Package NDC | Active ingredient | Establishment | Period | Source date | Normalization | Row hash |
|---|---|---|---|---|---|---|---|---|---|
outsourcing:2026-1:129 | 129 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | 2026-1 | 2026-10-13 | valid | 3f6c215993bb… |
outsourcing:2026-1:1480 | 1480 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | 2026-1 | 2026-10-13 | valid | ddd7bf1298ed… |
outsourcing:2026-1:178 | 178 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | 2026-1 | 2026-10-13 | valid | 83ffa550763f… |
outsourcing:2025-2:130 | 130 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | 2025-2 | 2026-10-13 | valid | 0b972adee88b… |
outsourcing:2025-2:1532 | 1532 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | 2025-2 | 2026-10-13 | valid | 11de7ee16280… |
outsourcing:2025-2:176 | 176 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | 2025-2 | 2026-10-13 | valid | b27315266aa8… |
outsourcing:2025-1:121 | 121 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | 2025-1 | 2026-10-13 | valid | fb63e352f931… |
outsourcing:2025-1:1272 | 1272 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | 2025-1 | 2026-10-13 | valid | 3b81e735937b… |
outsourcing:2025-1:1273 | 1273 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | 2025-1 | 2026-10-13 | valid | ce7a75720b58… |
outsourcing:2025-1:1614 | 1614 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | 2025-1 | 2026-10-13 | valid | 454a435520a4… |
outsourcing:2025-1:168 | 168 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | 2025-1 | 2026-10-13 | valid | eb58c3e2052a… |
outsourcing:2024-2:126 | 126 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | 2024-2 | 2026-10-13 | valid | ab3c9508e6c4… |
Parsed outsourcing-response revision rows#
These are physical source-row memberships from every distinct parsed response revision, not deduplicated current records.
| Parsed revision | Source JSON | Period | Source date | Product NDC | Package NDC | Active ingredient | Establishment | Parser | Row hash |
|---|---|---|---|---|---|---|---|---|---|
8f6618397ccf… | 129 | 2026-1 | 2026-10-13 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
8f6618397ccf… | 178 | 2026-1 | 2026-10-13 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
8f6618397ccf… | 1480 | 2026-1 | 2026-10-13 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
0b540c88a281… | 130 | 2025-2 | 2026-10-13 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
0b540c88a281… | 176 | 2025-2 | 2026-10-13 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
0b540c88a281… | 1532 | 2025-2 | 2026-10-13 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
e8f0a02c6277… | 121 | 2025-1 | 2026-10-13 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
e8f0a02c6277… | 168 | 2025-1 | 2026-10-13 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
e8f0a02c6277… | 1272 | 2025-1 | 2026-10-13 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
e8f0a02c6277… | 1273 | 2025-1 | 2026-10-13 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
e8f0a02c6277… | 1614 | 2025-1 | 2026-10-13 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
ab5e3ddbdea5… | 126 | 2024-2 | 2026-10-13 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
610bbcb3a755… | 129 | 2026-1 | 2026-10-06 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
610bbcb3a755… | 178 | 2026-1 | 2026-10-06 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
610bbcb3a755… | 1480 | 2026-1 | 2026-10-06 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
133d69db39e2… | 130 | 2025-2 | 2026-10-06 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
133d69db39e2… | 176 | 2025-2 | 2026-10-06 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
133d69db39e2… | 1532 | 2025-2 | 2026-10-06 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
790c65a73fbe… | 121 | 2025-1 | 2026-10-06 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
790c65a73fbe… | 168 | 2025-1 | 2026-10-06 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
790c65a73fbe… | 1272 | 2025-1 | 2026-10-06 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
790c65a73fbe… | 1273 | 2025-1 | 2026-10-06 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
790c65a73fbe… | 1614 | 2025-1 | 2026-10-06 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
62f3d4e8f094… | 126 | 2024-2 | 2026-10-06 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
3122cd800ba0… | 129 | 2026-1 | 2026-10-05 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
3122cd800ba0… | 178 | 2026-1 | 2026-10-05 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
3122cd800ba0… | 1480 | 2026-1 | 2026-10-05 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
6dba8ea2e057… | 130 | 2025-2 | 2026-10-05 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
6dba8ea2e057… | 176 | 2025-2 | 2026-10-05 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
6dba8ea2e057… | 1532 | 2025-2 | 2026-10-05 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
afcce5d51043… | 121 | 2025-1 | 2026-10-05 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
afcce5d51043… | 168 | 2025-1 | 2026-10-05 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
afcce5d51043… | 1272 | 2025-1 | 2026-10-05 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
afcce5d51043… | 1273 | 2025-1 | 2026-10-05 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
afcce5d51043… | 1614 | 2025-1 | 2026-10-05 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
e95ec19a3847… | 126 | 2024-2 | 2026-10-05 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
3cdff26f25c4… | 129 | 2026-1 | 2026-10-03 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f6c215993bb… |
3cdff26f25c4… | 178 | 2026-1 | 2026-10-03 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 83ffa550763f… |
3cdff26f25c4… | 1480 | 2026-1 | 2026-10-03 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ddd7bf1298ed… |
f9f132cf2e29… | 130 | 2025-2 | 2026-10-03 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0b972adee88b… |
f9f132cf2e29… | 176 | 2025-2 | 2026-10-03 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b27315266aa8… |
f9f132cf2e29… | 1532 | 2025-2 | 2026-10-03 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 11de7ee16280… |
b2be190fdf56… | 121 | 2025-1 | 2026-10-03 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | fb63e352f931… |
b2be190fdf56… | 168 | 2025-1 | 2026-10-03 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | eb58c3e2052a… |
b2be190fdf56… | 1272 | 2025-1 | 2026-10-03 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b81e735937b… |
b2be190fdf56… | 1273 | 2025-1 | 2026-10-03 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ce7a75720b58… |
b2be190fdf56… | 1614 | 2025-1 | 2026-10-03 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 454a435520a4… |
55dd4ef33968… | 126 | 2024-2 | 2026-10-03 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | ab3c9508e6c4… |
72a6e277ac8e… | 106 | 2026-1 | 2026-09-14 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b10fdb1cf516… |
72a6e277ac8e… | 155 | 2026-1 | 2026-09-14 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | c88738f6eef0… |
72a6e277ac8e… | 1478 | 2026-1 | 2026-09-14 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 35887ce0f05c… |
08b36ef05890… | 109 | 2025-2 | 2026-09-14 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 05fe7db797b4… |
08b36ef05890… | 155 | 2025-2 | 2026-09-14 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f872b4adaa0… |
08b36ef05890… | 1531 | 2025-2 | 2026-09-14 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 54fad64738ac… |
916689bd2062… | 104 | 2025-1 | 2026-09-14 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | dbc5d48f6d82… |
916689bd2062… | 150 | 2025-1 | 2026-09-14 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 410b04ab879a… |
916689bd2062… | 1270 | 2025-1 | 2026-09-14 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3032c2947904… |
916689bd2062… | 1271 | 2025-1 | 2026-09-14 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7804164bad8b… |
916689bd2062… | 1613 | 2025-1 | 2026-09-14 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 15d338ad4e19… |
95c52cefd374… | 109 | 2024-2 | 2026-09-14 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 58d90173f5c4… |
2ab9cc405f39… | 106 | 2026-1 | 2026-09-09 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b10fdb1cf516… |
2ab9cc405f39… | 155 | 2026-1 | 2026-09-09 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | c88738f6eef0… |
2ab9cc405f39… | 1478 | 2026-1 | 2026-09-09 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 35887ce0f05c… |
fd5fb1b994d2… | 109 | 2025-2 | 2026-09-09 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 05fe7db797b4… |
fd5fb1b994d2… | 155 | 2025-2 | 2026-09-09 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f872b4adaa0… |
fd5fb1b994d2… | 1531 | 2025-2 | 2026-09-09 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 54fad64738ac… |
30cb5f620df2… | 104 | 2025-1 | 2026-09-09 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | dbc5d48f6d82… |
30cb5f620df2… | 150 | 2025-1 | 2026-09-09 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 410b04ab879a… |
30cb5f620df2… | 1270 | 2025-1 | 2026-09-09 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3032c2947904… |
30cb5f620df2… | 1271 | 2025-1 | 2026-09-09 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7804164bad8b… |
30cb5f620df2… | 1613 | 2025-1 | 2026-09-09 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 15d338ad4e19… |
5eb6e0995025… | 109 | 2024-2 | 2026-09-09 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 58d90173f5c4… |
28e2d2e2e924… | 106 | 2026-1 | 2026-09-04 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b10fdb1cf516… |
28e2d2e2e924… | 155 | 2026-1 | 2026-09-04 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | c88738f6eef0… |
28e2d2e2e924… | 1478 | 2026-1 | 2026-09-04 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 35887ce0f05c… |
4c2d7e59059c… | 109 | 2025-2 | 2026-09-04 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 05fe7db797b4… |
4c2d7e59059c… | 155 | 2025-2 | 2026-09-04 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f872b4adaa0… |
4c2d7e59059c… | 1531 | 2025-2 | 2026-09-04 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 54fad64738ac… |
212960f5483f… | 104 | 2025-1 | 2026-09-04 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | dbc5d48f6d82… |
212960f5483f… | 150 | 2025-1 | 2026-09-04 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 410b04ab879a… |
212960f5483f… | 1270 | 2025-1 | 2026-09-04 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3032c2947904… |
212960f5483f… | 1271 | 2025-1 | 2026-09-04 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7804164bad8b… |
212960f5483f… | 1613 | 2025-1 | 2026-09-04 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 15d338ad4e19… |
90f6647f8168… | 109 | 2024-2 | 2026-09-04 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 58d90173f5c4… |
713773ee29f2… | 106 | 2026-1 | 2026-08-28 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b10fdb1cf516… |
713773ee29f2… | 155 | 2026-1 | 2026-08-28 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | c88738f6eef0… |
713773ee29f2… | 1478 | 2026-1 | 2026-08-28 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 35887ce0f05c… |
c56342f79c63… | 109 | 2025-2 | 2026-08-28 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 05fe7db797b4… |
c56342f79c63… | 155 | 2025-2 | 2026-08-28 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3f872b4adaa0… |
c56342f79c63… | 1531 | 2025-2 | 2026-08-28 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 54fad64738ac… |
0cae69414f92… | 104 | 2025-1 | 2026-08-28 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | dbc5d48f6d82… |
0cae69414f92… | 150 | 2025-1 | 2026-08-28 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 410b04ab879a… |
0cae69414f92… | 1270 | 2025-1 | 2026-08-28 | 83556-0201 | 83556-0201-2 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3032c2947904… |
0cae69414f92… | 1271 | 2025-1 | 2026-08-28 | 83556-0205 | 83556-0205-5 | Semaglutide | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7804164bad8b… |
0cae69414f92… | 1613 | 2025-1 | 2026-08-28 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 15d338ad4e19… |
4c022b95b63b… | 109 | 2024-2 | 2026-08-28 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 58d90173f5c4… |
9c779da112c4… | 106 | 2026-1 | 2026-08-26 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | b10fdb1cf516… |
9c779da112c4… | 155 | 2026-1 | 2026-08-26 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | c88738f6eef0… |
9c779da112c4… | 1478 | 2026-1 | 2026-08-26 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 35887ce0f05c… |
fb6d1ba14b13… | 109 | 2025-2 | 2026-08-26 | 83556-0101 | 83556-0101-1 | Bevacizumab | Turbare Manufacturing | ndc-aux-outsourcing-revision-2026-08-02-v1 | 05fe7db797b4… |